Patents by Inventor Adrian Vilalta

Adrian Vilalta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM TO PREDICT RESPONSE TO TREATMENTS FOR MENTAL DISORDERS
    Publication number: 20170253928
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.
    Type: Application
    Filed: March 6, 2017
    Publication date: September 7, 2017
    Inventors: Guangdan Zhu, Cindy Wang, Tanya Moreno, Andrew Hellman, Alok Tomar, Svetlana Ivanova Gramatikova, Aditi Chawla, Russell Kuo-fu Chan, Andria Del Tredici, Adrian Vilalta, K. David Becker, Michael Nova
  • METHOD AND SYSTEM TO PREDICT RESPONSE TO TREATMENTS FOR MENTAL DISORDERS
    Publication number: 20170051350
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to a psychiatric treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a psychiatric treatment.
    Type: Application
    Filed: April 29, 2016
    Publication date: February 23, 2017
    Inventors: Guangdan Zhu, Cindy Wang, Tanya Moreno, Andrew Hellman, Alok Tomar, Svetlana Ivanova Gramatikova, Aditi Chawla, Russell Kuo-fu Chan, Adriana Del Tredici, Adrian Vilalta, K. David Becker, Michael Nova
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 9205146
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: December 8, 2015
    Assignees: Vical Incorporated, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 9161973
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Grant
    Filed: August 14, 2014
    Date of Patent: October 20, 2015
    Assignees: Vical Incorporated, UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • METHOD AND SYSTEM TO PREDICT RESPONSE TO TREATMENTS FOR MENTAL DISORDERS
    Publication number: 20150292014
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.
    Type: Application
    Filed: March 12, 2014
    Publication date: October 15, 2015
    Applicant: Pathway Genomics Corporation
    Inventors: Guangdan Zhu, Cindy Wang, Tanya Moreno, Andrew Hellman, Alok Tomar, Svetlana Ivanova Gramatikova, Aditi Chawla, Russell Kuo-fu Chan, Andria Del Tredici, Adrian Vilalta, K. David Becker, Michael Nova
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20150030631
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Applicants: VICAL INCORPORATED, The University of Washington
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20150010597
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.
    Type: Application
    Filed: September 17, 2014
    Publication date: January 8, 2015
    Applicants: Vical Incorporated, The University Of Washington
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20150010596
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 8, 2015
    Applicants: Vical Incorporated, The University of Washington
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20140370055
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Application
    Filed: August 14, 2014
    Publication date: December 18, 2014
    Applicants: Vical Incorporated, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8852610
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8852611
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8840904
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP11/12 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 23, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8840903
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: September 23, 2014
    Assignee: Vical Incorporated
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • METHOD AND SYSTEM TO PREDICT RESPONSE TO TREATMENTS FOR MENTAL DISORDERS
    Publication number: 20140274764
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to a psychiatric treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a psychiatric treatment.
    Type: Application
    Filed: June 13, 2013
    Publication date: September 18, 2014
    Inventors: Guangdan Zhu, Michael McCarthy, John Kelsoe, Cindy Wang, Tanya Moreno, Andrew Hellman, Alok Tomar, Svetlana Ivanova Gramatikova, Aditi Chawla, Russell Kuo-fu Chan, Andria Del Tredici, Adrian Vilalta, K. David Becker
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8834894
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 16, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 8828408
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP13/14 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 9, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Influenza virus vaccine composition and methods of use
    Patent number: 8821890
    Abstract: The present invention is directed to compositions and methods for enhancing the immune response of a human in need of protection against influenza virus (IV) infection by administering in vivo, into a tissue of the human, at least one polynucleotide comprising one or more regions of nucleic acid encoding an IV protein or a fragment, a variant, or a derivative thereof, or a protein encoded thereby. The polynucleotide is incorporated into the cells of the human in vivo, and an immunologically effective amount of an immunogenic epitope of an IV, or a fragment, variant, or derivative thereof is produced in vivo. The IV protein (in purified form or in the form of an inactivated IV vaccine) is also administered in an immunologically effective amount.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: September 2, 2014
    Assignee: Vical Incorporated
    Inventors: Catherine J. Luke, Adrian Vilalta, Mary K. Wloch, Thomas G. Evans, Andrew J. Geall, Gretchen S. Jimenez
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20130273108
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20130273107
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20120328657
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 27, 2012
    Applicants: THE UNIVERSITY OF WASHINGTON, Vical Incorporated
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle